| Year |
Citation |
Score |
| 2020 |
Dean P, Hooks S. Role of RGS10 in the ovarian cancer microenvironment The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05803 |
0.307 |
|
| 2020 |
Wendimu MY, Alqinyah M, Vella S, Moreno SN, Hooks S. Regulator of G protein Signaling 10 (RGS10) functionally interacts with store‐operated calcium entry machinery to regulate COX‐2 and TNF‐α in Microglia The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04451 |
0.378 |
|
| 2018 |
Alqinyah M, Almutairi F, Wendimu MY, Hooks S. RGS10 regulates the expression of Cyclooxygenase-2 and Tumor Necrosis Factor alpha through a G-protein-independent mechanism. Molecular Pharmacology. PMID 30049816 DOI: 10.1124/Mol.118.111674 |
0.498 |
|
| 2017 |
Alqinyah M, Hooks SB. Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins. Cellular Signalling. PMID 29042285 DOI: 10.1016/J.Cellsig.2017.10.007 |
0.436 |
|
| 2017 |
Callihan P, Alqinyah M, Hooks SB. Sphingosine-1-Phosphate (S1P) Signaling in Neural Progenitors. Methods in Molecular Biology (Clifton, N.J.). PMID 28361481 DOI: 10.1007/7651_2017_3 |
0.325 |
|
| 2016 |
Alqinyah M, Maganti N, Ali MW, Yadav R, Gao M, Weng HR, Greer SF, Hooks SB. Regulator of G-protein Signaling 10 (RGS10) expression is transcriptionally silenced in activated microglia by histone deacetylase activity. Molecular Pharmacology. PMID 28031332 DOI: 10.1124/Mol.116.106963 |
0.354 |
|
| 2015 |
Hooks SB, Murph MM. Cellular deficiency in the RGS10 protein facilitates chemoresistant ovarian cancer. Future Medicinal Chemistry. 7: 1483-9. PMID 26293348 DOI: 10.4155/Fmc.15.81 |
0.438 |
|
| 2015 |
Hung SW, Marrache S, Cummins S, Bhutia YD, Mody H, Hooks SB, Dhar S, Govindarajan R. Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach. Cancer Letters. 359: 233-40. PMID 25600708 DOI: 10.1016/J.Canlet.2015.01.017 |
0.35 |
|
| 2015 |
Hooks S. Abstract POSTER-BIOL-1317: Releasing the brakes on ovarian cancer cell survival: epigenetic suppression of RGS10 in ovarian cancer chemoresistance Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Biol-1317 |
0.429 |
|
| 2014 |
Callihan P, Ali MW, Salazar H, Quach N, Wu X, Stice SL, Hooks SB. Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by lysophosphatidic acid, sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptor. Asn Neuro. 6. PMID 25424429 DOI: 10.1177/1759091414558416 |
0.458 |
|
| 2014 |
Tuggle K, Ali MW, Salazar H, Hooks SB. Regulator of G protein signaling transcript expression in human neural progenitor differentiation: R7 subfamily regulation by DNA methylation. Neuro-Signals. 22: 43-51. PMID 24903911 DOI: 10.1159/000362128 |
0.423 |
|
| 2014 |
Cacan E, Ali MW, Boyd NH, Hooks SB, Greer SF. Inhibition of HDAC1 and DNMT1 modulate RGS10 expression and decrease ovarian cancer chemoresistance. Plos One. 9: e87455. PMID 24475290 DOI: 10.1371/Journal.Pone.0087455 |
0.392 |
|
| 2013 |
Ali MW, Cacan E, Liu Y, Pierce JY, Creasman WT, Murph MM, Govindarajan R, Eblen ST, Greer SF, Hooks SB. Transcriptional suppression, DNA methylation, and histone deacetylation of the regulator of G-protein signaling 10 (RGS10) gene in ovarian cancer cells. Plos One. 8: e60185. PMID 23533674 DOI: 10.1371/Journal.Pone.0060185 |
0.384 |
|
| 2013 |
Hooks SB. Kinase coupled receptors and G-protein coupled receptors regulate neural stem cell differentiation via common signaling pathways: Emerging evidence for convergent regulation New Developments On Signal Transduction Research. 13-36. |
0.387 |
|
| 2012 |
Callihan P, Hooks SB. Sphingosine-1-phosphate signaling in neural progenitors. Methods in Molecular Biology (Clifton, N.J.). 874: 193-200. PMID 22528449 DOI: 10.1007/978-1-61779-800-9_15 |
0.435 |
|
| 2012 |
Callihan P, Zitomer NC, Stoeling MV, Kennedy PC, Lynch KR, Riley RT, Hooks SB. Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells. Neuropharmacology. 62: 988-96. PMID 22016110 DOI: 10.1016/J.Neuropharm.2011.10.005 |
0.677 |
|
| 2012 |
Altman MK, Ali MW, Callihan PC, Hooks SB, Murph MM. Abstract 2140: Regulator of G-protein signaling 2 blunts cellular viability mediated by a stabilized lysophosphatidic acid analogue (2S-OMPT) in the presence of chemotherapy in an ovarian cancer cell model of chemoresistance Cancer Research. 72: 2140-2140. DOI: 10.1158/1538-7445.Am2012-2140 |
0.549 |
|
| 2011 |
Callihan P, Mumaw J, Machacek DW, Stice SL, Hooks SB. Regulation of stem cell pluripotency and differentiation by G protein coupled receptors. Pharmacology & Therapeutics. 129: 290-306. PMID 21073897 DOI: 10.1016/J.Pharmthera.2010.10.007 |
0.447 |
|
| 2010 |
Hooks SB, Callihan P, Altman MK, Hurst JH, Ali MW, Murph MM. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells. Molecular Cancer. 9: 289. PMID 21044322 DOI: 10.1186/1476-4598-9-289 |
0.684 |
|
| 2009 |
Hurst JH, Hooks SB. Regulator of G-protein signaling (RGS) proteins in cancer biology. Biochemical Pharmacology. 78: 1289-97. PMID 19559677 DOI: 10.1016/J.Bcp.2009.06.028 |
0.672 |
|
| 2009 |
Hurst JH, Hooks SB. Lysophosphatidic acid stimulates cell growth by different mechanisms in SKOV-3 and Caov-3 ovarian cancer cells: distinct roles for Gi- and Rho-dependent pathways. Pharmacology. 83: 333-47. PMID 19420982 DOI: 10.1159/000217582 |
0.69 |
|
| 2009 |
Hurst JH, Mendpara N, Hooks SB. Regulator of G-protein signalling expression and function in ovarian cancer cell lines. Cellular & Molecular Biology Letters. 14: 153-74. PMID 18979070 DOI: 10.2478/S11658-008-0040-7 |
0.696 |
|
| 2009 |
SchianodiCola JJ, Ray SD, Hurst JH, Hooks SB, Braga PC, Sasso MD, Culici M, Spallino A, Falchi M, Bertelli A, Morelli R, Scalzo RL, Yung E, Yarmush JM, Weinberg J, et al. Contents Vol. 83, 2009 Pharmacology. 83. DOI: 10.1159/000224626 |
0.537 |
|
| 2009 |
SchianodiCola JJ, Ray SD, Hurst JH, Hooks SB, Braga PC, Sasso MD, Culici M, Spallino A, Falchi M, Bertelli A, Morelli R, Scalzo RL, Yung E, Yarmush JM, Weinberg J, et al. Subject Index Vol. 83, 2009 Pharmacology. 83: 387-388. DOI: 10.1159/000224625 |
0.532 |
|
| 2008 |
Hurst JH, Mumaw J, Machacek DW, Sturkie C, Callihan P, Stice SL, Hooks SB. Human neural progenitors express functional lysophospholipid receptors that regulate cell growth and morphology. Bmc Neuroscience. 9: 118. PMID 19077254 DOI: 10.1186/1471-2202-9-118 |
0.693 |
|
| 2008 |
Hooks SB, Cummings BS. Role of Ca2+-independent phospholipase A2 in cell growth and signaling. Biochemical Pharmacology. 76: 1059-67. PMID 18775417 DOI: 10.1016/J.Bcp.2008.07.044 |
0.438 |
|
| 2008 |
Hurst JH, Henkel PA, Brown AL, Hooks SB. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells. Cellular Signalling. 20: 381-9. PMID 18083345 DOI: 10.1016/J.Cellsig.2007.10.026 |
0.703 |
|
| 2008 |
Hooks SB, Martemyanov K, Zachariou V. A role of RGS proteins in drug addiction. Biochemical Pharmacology. 75: 76-84. PMID 17880927 DOI: 10.1016/J.Bcp.2007.07.045 |
0.372 |
|
| 2006 |
Hooks S. G Protein-Coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity. Methods and Principles in Medicinal Chemistry. Vol. 24 Edited by Roland Seifert and Thomas Wieland. Wiley-VCH, Weinheim, Germany. 2005. xxvii + 275 pp. 17.5 × 24.5 cm. ISBN 3527308199. $170.00. Journal of Medicinal Chemistry. 49: 5025-5026. DOI: 10.1021/Jm0680272 |
0.371 |
|
| 2004 |
Jones MB, Siderovski DP, Hooks SB. The G betagamma dimer as a novel source of selectivity in G-protein signaling: GGL-ing at convention. Molecular Interventions. 4: 200-14. PMID 15304556 DOI: 10.1124/Mi.4.4.4 |
0.32 |
|
| 2004 |
Wu YL, Hooks SB, Harden TK, Dohlman HG. Dominant-negative inhibition of pheromone receptor signaling by a single point mutation in the G protein alpha subunit. The Journal of Biological Chemistry. 279: 35287-97. PMID 15197187 DOI: 10.1074/Jbc.M404896200 |
0.615 |
|
| 2003 |
Bodor ET, Waldo GL, Hooks SB, Corbitt J, Boyer JL, Harden TK. Purification and functional reconstitution of the human P2Y12 receptor. Molecular Pharmacology. 64: 1210-6. PMID 14573771 DOI: 10.1124/Mol.64.5.1210 |
0.369 |
|
| 2003 |
Hooks SB, Waldo GL, Corbitt J, Bodor ET, Krumins AM, Harden TK. RGS6, RGS7, RGS9, and RGS11 stimulate GTPase activity of Gi family G-proteins with differential selectivity and maximal activity. The Journal of Biological Chemistry. 278: 10087-93. PMID 12531899 DOI: 10.1074/Jbc.M211382200 |
0.306 |
|
| 2001 |
Hooks SB, Santos WL, Im DS, Heise CE, Macdonald TL, Lynch KR. Lysophosphatidic acid-induced mitogenesis is regulated by lipid phosphate phosphatases and is Edg-receptor independent. The Journal of Biological Chemistry. 276: 4611-21. PMID 11042183 DOI: 10.1074/Jbc.M007782200 |
0.694 |
|
| 1999 |
Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, Connolly BM, Bai C, Austin CP, Chateauneuf A, Stocco R, ... ... Hooks SB, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 399: 789-93. PMID 10391245 DOI: 10.1038/21658 |
0.504 |
|
| 1999 |
Hopper DW, Ragan SP, Hooks SB, Lynch KR, Macdonald TL. Structure--activity relationships of lysophosphatidic acid: conformationally restricted backbone mimetics. Journal of Medicinal Chemistry. 42: 963-70. PMID 10090779 DOI: 10.1021/Jm970809V |
0.573 |
|
| 1999 |
Im DS, Hooks SB, Lynch KR. Molecular pharmacology of lipid phosphoric acid receptors Proceedings of the Western Pharmacology Society. 42: 144. |
0.473 |
|
| 1998 |
Hooks SB, Ragan SP, Lynch KR. Identification of a novel human phosphatidic acid phosphatase type 2 isoform. Febs Letters. 427: 188-92. PMID 9607309 DOI: 10.1016/S0014-5793(98)00421-9 |
0.397 |
|
| 1998 |
Hooks SB, Ragan SP, Hopper DW, Hönemann CW, Durieux ME, Macdonald TL, Lynch KR. Characterization of a receptor subtype-selective lysophosphatidic acid mimetic. Molecular Pharmacology. 53: 188-94. PMID 9463475 DOI: 10.1124/Mol.53.2.188 |
0.527 |
|
| Show low-probability matches. |
